VivoSeq
Other

Port Wine Stains

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Port Wine Stains is an early-stage landscape with 0 programs across 1 company. The most active players are AFT Pharmaceuticals, Ltd..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

25/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

AFT Pharmaceuticals, Ltd.

1 program

Phase 2

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Terminated1 · 25%
Completed1 · 25%
Unknown status1 · 25%
Not yet recruiting1 · 25%

Clinical Trials

Trial Activity

Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus
Terminated·EErasmus Medical Center·N/A·NCT02214706·17 enrolled
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
Completed·UUniversity of California, Irvine·N/A·NCT00556946·17 enrolled
Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol Gel
Unknown status·—·Phase 3·NCT01272609·44 enrolled
Rapamycin Dose-Ranging Efficacy Study: A Phase II, Proof of Concept, Double-blind, Placebo-controlled, Randomized, Parallel-group, Dose-response Comparison of the Effects of Different Strengths of Rapamycin Cream Applied Topically in Subjects Diagnosed With Port Wine Stains
Not yet recruiting·AAFT Pharmaceuticals, Ltd.·Phase 2·NCT07436611·30 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)